Retatrutide 5mg
Retatrutide (LY-3437943) targets GLP-1, GIP, and GCGR receptors and is claimed to show promise as an anti-obesity agent.
- It shows promise as an anti-obesity agent.
AI Readiness
Good foundation, but some important product data is still missing.
71%